Literature DB >> 12672543

Galanin-like peptide is target for regulation by orexin in the rat hypothalamus.

Fumiko Takenoya1, Kenji Aihara, Hisayuki Funahashi, Hirokazu Matsumoto, Tetsuya Ohtaki, Shinobu Tsurugano, Shuori Yamada, Sachi Katoh, Haruaki Kageyama, Masao Takeuchi, Seiji Shioda.   

Abstract

Galanin-like peptide (GALP) is a newly discovered 60 amino acid peptide from the porcine hypothalamus. GALP has been shown to be expressed predominantly in the arcuate nucleus (ARC) of the rat hypothalamus, a region considered to be one of the most important feeding-regulating centers in the brain. GALP-containing neurons in the ARC express leptin receptors, but relationships between GALP and other feeding-regulating neurons have not yet been fully elucidated. Given that Orexin (OX)-containing neurons make synaptic inputs to the ARC, we thus examined the relationship between GALP and OX in the ARC by use of a dual immunostaining technique. OX-immunoreactive fibers appeared to be closely apposed to GALP-immunoreactive cell bodies and their processes. We also examined whether the OX receptor, OX(1)-R was expressed in the GALP-containing neurons. Immunoreactivity for both OX(1)-R and GALP was detectable in 9.6 % neurons (range 4.2-14.6%) in the ARC. These findings strongly suggest that GALP may participate in the regulation of feeding behavior under the influence of leptin and OX.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12672543     DOI: 10.1016/s0304-3940(03)00120-4

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  2 in total

Review 1.  Galanin-like peptide (GALP) is a hypothalamic regulator of energy homeostasis and reproduction.

Authors:  Catherine Lawrence; Gregory S Fraley
Journal:  Front Neuroendocrinol       Date:  2010-06-15       Impact factor: 8.606

2.  Autonomic nervous system-mediated effects of galanin-like peptide on lipid metabolism in liver and adipose tissue.

Authors:  Satoshi Hirako; Nobuhiro Wada; Haruaki Kageyama; Fumiko Takenoya; Yoshihiko Izumida; Hyounju Kim; Yuzuru Iizuka; Akiyo Matsumoto; Mai Okabe; Ai Kimura; Mamiko Suzuki; Satoru Yamanaka; Seiji Shioda
Journal:  Sci Rep       Date:  2016-02-19       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.